Verge Genomics
Leadership Approach Pipeline Partnerships News Careers
LeadershipApproachPipelinePartnershipsNewsCareers
Verge Genomics
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
Press ReleaseRob MaguireJuly 8, 2021
Verge Genomics Presents Preclinical Data Supporting Broad-Spectrum Potential of Its Novel, Oral Antiviral at the 31st European Congress of Clinical Microbiology & Infectious Diseases
EventsRob MaguireJuly 7, 2021
AI Transforms Genomic Data into Actionable Insights
NewsRob MaguireJuly 2, 2021
Verge Genomics Announces the Addition of Mario Saltarelli, M.D., Ph.D., to its Scientific Advisory Board
Press ReleaseRob MaguireMay 12, 2021
Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer
NewsRob MaguireMay 5, 2021
Biotech Tilts at the Tipping Point of Gender Equality
NewsRob MaguireApril 29, 2021
Covid-19 Devastated Some Industries But Accelerated AI Use By Companies Across The Country
NewsRob MaguireApril 5, 2021
Verge Genomics Announces the Addition of Steve Kanes to its Board of Directors
NewsRob MaguireMarch 9, 2021
Verge Genomics Announces Research Collaboration with the Sheffield Institute for Translational Neuroscience
Press ReleaseRob MaguireFebruary 2, 2021
Verge Genomics joins the Neurofilament Light Surveillance Project to Accelerate New Approaches to Diagnosing and Treating Frontotemporal Dementia
Press ReleaseRob MaguireOctober 29, 2020
Verge Genomics Announces Publication of New Approach for Uncovering Novel Drug Targets from Human Genetics
Press ReleaseRob MaguireOctober 5, 2020
Verge Genomics Announces the Addition of Rita Balice-Gordon, PhD, to its Scientific Advisory Board
Press ReleaseRob MaguireJune 24, 2020
Verge Genomics Awarded as Technology Pioneer by World Economic Forum
Press ReleaseRob MaguireJune 18, 2020
Verge Genomics to advance its inhibitors of PIKfyve for the treatment of ALS and COVID-19
Press ReleaseRob MaguireJune 11, 2020
Verge Genomics Announces the Addition of Two Renowned Neuroscience Drug Development Industry Experts to its Advisory Board
Press ReleaseRob MaguireDecember 11, 2019
Verge Genomics Appoints Jane Rhodes, Ph.D., M.B.A. as Chief Business Officer
Press ReleaseRob MaguireSeptember 11, 2019
Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discovery
Press ReleaseRob MaguireJuly 16, 2018
Verge Genomics Announces Landmark Effort to Generate Field's First Single Cell Data from Patients with Parkinson's Disease
Press ReleaseRob MaguireMay 21, 2018
Verge Genomics Announces Landmark Effort to Generate Field's First Single Cell Data from Patients with Parkinson's Disease
Press ReleaseRob MaguireMay 18, 2018
Verge Genomics joins Genomics England's Discovery Forum to transform pioneering research into frontline patient treatments
Press ReleaseRob MaguireFebruary 8, 2018
Newer Older
  • Home
  • Leadership
  • Approach
  • Pipeline
  • Accessibility
  • Partnerships
  • News
  • Careers
  • Privacy
Verge Genomics Logo

455 Market St.
Ste 1940 PMB 805233
San Francisco, California
94105-2448 US

  • LinkedIn icon graphic
    X logo icon graphic
  • info@vergegenomics.com
Copyright 2023